Professional Overview
Kendel Orr is an accomplished pharmaceutical executive with over 14 years of experience driving commercial and operational success in the ophthalmology and rare disease segments. As the Head of Strategic Accounts & Commercial Operations for the U.S. at Neurotech Pharmaceuticals, Inc., she leads a team responsible for developing and executing strategic account management initiatives to drive growth and optimize commercial operations.
Experience Summary
Current Role
In her current position at Neurotech Pharmaceuticals, Kendel is responsible for overseeing the company's strategic account management and commercial operations across the United States. She leads a team of experienced professionals in developing and implementing tailored account strategies to foster strong partnerships with key healthcare providers, payers, and strategic customers. Under her leadership, the team has achieved significant improvements in customer engagement, market access, and revenue growth.
Career Progression
Prior to joining Neurotech, Kendel held several progressive leadership roles in the pharmaceutical industry, including Area Sales Director - Eastern U.S. - Retina/Ophthalmology at Apellis Pharmaceuticals, National Sales Director - Ophthalmology Surgery and Retina/Rare Disease at EyePoint Pharmaceuticals, and Regional Business Director - Midwest - Ophthalmology at Shire. Throughout her career, she has consistently demonstrated the ability to drive sales performance, optimize commercial operations, and build strong relationships with healthcare stakeholders.
Academic Background
Kendel holds a Bachelor of Science degree in Business Administration from the University of Kansas, where she graduated with honors.
Areas of Expertise
- Strategic account management and customer relationship building
- Commercial operations optimization and process improvement
- Cross-functional team leadership and collaboration
- Market access and reimbursement strategy development
- Ophthalmology and rare disease therapeutic area expertise
Professional Impact
During her tenure at Apellis Pharmaceuticals, Kendel led the successful launch of a new ophthalmology product, which resulted in a 25% increase in market share within the first year. At EyePoint Pharmaceuticals, she spearheaded the implementation of a data-driven sales and marketing strategy that contributed to a 30% growth in revenue for the ophthalmology and rare disease business units.
Conclusion
With her extensive experience, strategic mindset, and proven track record of driving commercial success, Kendel Orr is well-positioned to continue making a significant impact in the pharmaceutical industry. As the Head of Strategic Accounts & Commercial Operations for the U.S. at Neurotech Pharmaceuticals, she is dedicated to leveraging her expertise to help the company achieve its growth objectives and deliver innovative treatments to patients in need.
